Bayer AG operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bayer AG with three other
companies in this sector in the United States:
sales of $53.17 billion
of which 66%
was Innovative Medicines),
Merck & Co. , Inc.
of which 89%
was Merck Pharmaceutical), and
of which 56%
Bayer AG reported sales of $46.64 billion
December of 2018.
increase of 16.9%
versus 2017, when the company's sales were $39.89 billion.
Despite this increase, sales are still
below the level achieved in 2016, when Bayer AG
reported sales of $51.62 billion.
Sales of Cropscience saw an increase
that was more than double the company's growth rate: sales were up
54.1% in 2018, from
$10.91 billion to $16.81 billion.
Bayer AG also saw significant increases in sales in
All Other Segments (up 45.4% to $1.89 billion)
Not all segments of Bayer AG experienced an increase in sales in 2018:
sales of Consumer Care fell 3.8% to $6.42 billion.
Bayer AG also experienced decreases in sales in
Animal Health (down 1.2% to $1.77 billion)